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Abstract
Polycomb Group (PcG) proteins represent a conserved family of developmental regulators that
mediate heritable transcriptional silencing by modifying chromatin states. One PcG complex, the
PRC2 complex, is composed of several proteins, including the histone H3 lysine 27 (H3K27)
methyltransferase EZH2 and the WD-repeat protein EED. Histone H3K27 can be mono-
(H3K27me1), di- (H3K27me2), or trimethylated (H3K27me3). However, it remains unclear what
regulates the number of methyl groups added to H3K27 in a particular nucleosome. In mammalian
cells, EED is present as four distinct isoforms, which are believed to be produced by utilizing four
distinct, in-frame translation start sites in a common Eed mRNA. A mutation that disables all four
EED isoforms produces defects in H3K27 methylation.1 To assess the roles of individual EED
isoforms in H3K27 methylation, we first characterized three of the four EED isoform start sites and
then demonstrated that individual isoforms are not necessary for H3K27me1, H3K27me2, or
H3K27me3. Instead, we show that the core WD-40 motifs and the histone binding region of EED
alone are sufficient for the generation of all three marks, demonstrating that EED isoforms do not
control the number of methyl groups added to H3K27.
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Introduction
Polycomb Group (PcG) proteins are a conserved family of development regulators that modify
chromatin states in order to mediate heritable transcriptional silencing. PcG-mediated
repression is important in diverse biological processes including X-chromosome inactivation,
genomic imprinting, and segmental patterning.2; 3; 4; 5; 6; 7; 8; 9; 10 One PcG complex, the
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PRC2 complex, is composed of several bona fide PcG proteins, including the histone H3 lysine
27 (H3K27) methyltransferase EZH2 and the WD-repeat protein EED.10; 11; 12; 13
Histone H3K27 can be mono- (H3K27me1), di- (HeK27me2), or trimethylated (H3K27me3).
14 H3K27me3 is a repressive histone modification that localizes to confirmed targets of PcG
silencing, including the inactive X-chromosome.2; 3; 15; 16; 17 This mark mediates its
repressive effect by recruiting to chromatin or at least stabilizing the association of a second
PcG complex, PRC1.18; 19; 20; 21 Conversely, the functions of H3K27me1 and H3K27me2
are not known, although H3K27me1 was recently shown to be present throughout euchromatic
regions but absent in the vicinity of the start sites of active genes.22
While EZH2’s role as the catalytic subunit of PRC2 has been clearly demonstrated, the
functions of noncatalytic PRC2 subunits remain poorly defined. Both EED and the Zn-finger
protein SUZ12 are required to maintain the integrity of PRC2, and mutations in both genes
cause EZH2 to become destabilized.1; 23 Additionally, both in vivo and in vitro, EED and
SUZ12 are required for normal PRC2-mediated H3K27 methylation.1; 23; 24 However,
precise mechanistic details of these functions remain unclear.
Four EED isoforms are found in mammals, and these isoforms are thought to be produced by
utilizing four in-frame translation start sites in the Eed mRNA. EED isoform usage is regulated
developmentally, leading to speculation that EED could also function as a PRC2 regulatory
subunit.25 Additionally, EED-2, which has only been observed in undifferentiated stem cells
and in tumors, has been proposed to be important in maintaining developmental plasticity.26
However, definitive biochemical functions of the various EED isoforms have not been
demonstrated. Previous work using in vitro methyltransferase assays postulated that EED
isoforms control the substrate specificity of the PRC2 complex. In those initial studies, the
largest isoforms, EED-1 and EED-2 appeared to direct EZH2 methyltransferase activity
towards histone H1K26, whereas EED-3 and EED-4 appeared to direct EZH2
methyltransferase activity towards H3K27.25 However, a second recent study that also utilized
in vitro methyltransferase assays failed to detect any difference in the histone substrate
preference of PRC2 complexes with or without EED-1 or EED-2.27
Given this discrepancy, in the present study, we aimed to define regions of EED required for
each H3K27 methylation state in vivo using mouse embryonic stem (ES) cells that are wild-
type or mutant for Eed. Because all four known EED isoforms associate with EZH2, we
examined whether these isoforms might control the number of methyl groups added to H3K27
in a particular nucleosome.25; 26 To this end, we definitively characterize three of the four
EED isoform start sites and demonstrate that individual isoforms are not necessary for
H3K27me1, H3K27me2, or H3K27me3. These results indicate that EED isoforms do not
control the enzymatic activity of the PRC2 complex. Instead, we show that EED’s core WD-40
motifs and histone binding region alone are sufficient for the generation of all three marks.
Results
Distinct localization of H3K27 methylation states
Unlike mouse stem cell lines, differentiated mouse cells, such as murine embryonic fibroblasts
(MEFs), have a striking nuclear architecture, in which regions of the genome packaged as part
of the pericentric heterochromatin are clearly visible by DAPI staining as DNA-rich foci. Using
this characteristic DNA staining pattern to provide landmarks, we assessed the localization of
H3K27me1, H3K27me2 and H3K27me3 in CD1 MEFs (Figure 1). For these experiments, we
used antibodies specific for each H3K27 methylation state. The specificities of these antibodies
have been demonstrated previously by competition assays.14 Additionally, positive staining
with all three antibodies is lost in Eed mutant embryonic stem (ES) cells and trophoblast stem
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(TS) cells.1 Because methylation defects at other lysine residues have not been observed in
Eed mutant ES and TS cells, these results strengthen the conclusion that the antibodies do not
cross-react with methyl marks at other residues.
As previously reported, large foci of H3K27me1 colocalized with the DNA-rich pericentric
heterochromatin (Figure 1A and 14). Conversely, H3K27me2 and H3K27me3 were
specifically excluded from these regions, instead staining in a pattern reciprocal to that of
H3K27me1 (Figures 1B and 1C, Supplementary Figure 1). HP1-α, an established marker of
pericentric heterochromatin,28; 29; 30 was also enriched in the DNA-rich foci, confirming the
identity of these regions (Figure 1D). Finally, H3K27me2 and H3K27me3, though largely
colocalized (Supplementary Figure 2), were distinguished by the characteristic enrichment of
H3K27me3 on the inactive X-chromosome in female MEFs (Figure 1B and 1C).
In addition to confirming and establishing global localization patterns of H3K27me1, -me2,
and –me3, the distinct staining patterns confirm that the H3K27 antibodies are each specific
for one H3K27 methylation state and do not cross-react with histones harboring other H3K27
methylation states.
Characterization of EED isoforms expressed in wild-type ES cells
The distinct localization patterns of the three H3K27 methylation states indicates that the
number of methyl groups added to H3K27 in a particular nucleosome is a regulated process.
Because EED has previously been posited to play a regulatory role in PRC2-mediated histone
methylation,25 we aimed to define regions of EED required for H3K27me1, H3K27me2, and
H3K27me3. As a first step, we attempted to discern which EED isoforms are required for
H3K27 methylation by rescuing Eed mutant embryonic stem (ES) cells, which lack detectable
levels of endogenous H3K27me1, H3K27me2, and H3K27me3,1 with constructs expressing
individual EED isoforms. However, before a systematic series of rescue experiments was
performed, we attempted to confirm the identities of the EED isoforms.
Previous work indicates that all four EED isoforms are present in wild-type, undifferentiated
mouse ES cells.26 However, we were consistently only able to resolve three isoforms in
multiple, independently-derived ES cell lines, as well as in TS cells (Figure 2 and data not
shown). To assess whether our electrophoresis conditions would allow us to resolve all four
EED isoforms and, if so, to confirm the identities of the three observed isoforms, we compared
the isoforms present in our ES cells to the isoforms present in HeLa cells and in mouse Wap-
T121 mammary tumors. Previous work has demonstrated that EED-1, EED-3, and EED-4 are
expressed in HeLa cells and that EED-2 is upregulated in many mouse tumors.26 Consistent
with those reports, we observed high levels of EED-1, EED-3 and EED-4 and much lower
levels of EED-2 in HeLa cells (Figure 2A). Similarly, EED-2, along with EED-3 and EED-4,
was observed in Wap-T121 breast tumors (Figure 2B). Comparison of the isoforms present in
those sources with the isoforms present in our embryonic stem cells suggests that we observe
isoforms 1, 3, and 4 but not 2 in our ES cells (Figure 2).
Kuzmichev et al. demonstrated that EED-2 is rapidly downregulated when ES cells are
stimulated to differentiate.25 Hence, the most parsimonious explanation for our failure to
dectect four EED isoforms is that the ES cells employed were beginning to differentiate when
they were harvested, causing a downregulation of EED-2. One possible explanation for such
differentiation would be the removal of the cells from fibroblast feeders prior to harvesting in
order to minimize feeder contamination in our immunoblotting assays. To avoid this
complication, we also analyzed EED isoforms in E14 ES cells, which are feeder independent,
31 but were still able to detect only three isoforms (Figure 2).
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Embryonic stem cells, trophoblast stem cells, and primitive endoderm-derived XEN cells are
the only known cell types that can be derived from mouse embryos prior to gastrulation, the
embryonic stage when Eed mutant embryos arrest.32; 33; 34; 35; 36 Because only three EED
isoforms were resolved in our ES and TS cells and because only trace levels of EED are detected
in XEN cells (data not shown), we restricted our analysis to EED isoforms 1, 3, and 4.
Deletion mapping of EED isoform start sites
Although most proteins initiate translation at methionine-encoding AUG codons, an increasing
number of proteins are recognized to initiate translation from non-AUG codons. Often, these
alternative start sites generate upstream isoforms of proteins also translated from downstream,
canonical AUG initiation codons, and typically, the alternative codons differ from the canonical
AUG sequence at only one of the three nucleotide positions.37; 38 For instance, Fibroblast
Growth Factor-2 (FGF2) is present as five isoforms in mammalian cells, with four CUG
initiation codons upstream of a canonical AUG start site, and Vascular Endothelial Growth
Factor (VEGF) is translated from both an upstream CUG and a downstream AUG.39; 40; 41;
42; 43 Consistent with both of these trends, the upstream EED-1 and EED-2 are postulated to
initiate translation from non-canonical GUG codons at positions 169–171 and 274–276 in the
Eed cDNA, respectively, and the putative start sites for EED-3 and EED-4 are canonical AUG
sequences at positions 451–453 and 493–495 (Figure 3A and Supplementary Figure 3).25; 44
Overall, mouse and human EED are very similar proteins. In fact, the predicted EED-3 and
EED-4 isoforms are 100% identical between the two species.45 However, the sequences
between the putative EED-1 and EED-2 start sites, are much more variable.45 Given the abrupt
boundary between highly variable and nearly identical sequences, we questioned whether the
actual EED-1 start site might be further 3′ than previously reported.
To map EED isoform start sites, we generated a series of Eed expression constructs
progressively truncated at the 5′ end of the Eed cDNA (Figure 3A). Individual constructs were
then transiently transfected into Eed mutant ES cells, which lack detectable endogenous EED,
and EED isoform expression was assessed by Western blotting. Because isoform expression
could be lost either by deleting past an isoform start site or by deleting an upstream regulatory
element required for translation from an intact start site, the absence of a band is uninformative
in this assay. However, the continued presence of an isoform after its putative start site has
been deleted is strong evidence that the actual start site must be further downstream. Notably,
after transfection, the furthest 5′ intact translation start site was generally utilized preferentially
to downstream translation start sites (Figure 3). This observation suggests that regulated usage
of the various EED translation start sites is not simply a consequence of the interaction between
trans-acting factors and sequences present in the message but instead may be influenced by
upstream regulatory events.
Consistent with the relaxed sequence conservation between mouse and human Eed sequences
beginning with and immediately downstream from GUG 169–171, EED-1 was expressed from
constructs truncated 32 (Δ201) and even 88 (Δ257) nucleotides beyond the reported EED-1
start site, suggesting that EED-1 may not initiate translation at GUG 169–171 as previously
proposed (Figure 3B). EED-1 expression was lost only after deleting the 5′ 312 nucleotides of
the Eed cDNA, a deletion extending 143 nucleotides beyond the reported EED-1 start site and
38 nucleotides beyond the published EED-2 start site (Figure 3B). Consistent with the
published identity of the EED-3 start site at AUG 451–453, this isoform was observed after
deleting the 5′ 417 nucleotides but not after deleting the 5′ 455 nucleotides (Figure 3B). Finally,
EED-4 was present even in the largest truncation, which deleted the 5′ 455 nucleotides,
consistent with the published EED-4 start site residing at AUG 493–495 (Figure 3B). Notably,
our ability to detect EED-1, EED-3, and EED-4 from this series of cDNA expression constructs
Montgomery et al. Page 4













confirms that alternative splicing of exons within the EED coding sequence is not responsible
for the production of these three isoforms.
Confirmation of EED isoform start sites
To verify that GUG 169–171 is upstream of the actual EED-1 start site, we forced expression
from this codon by replacing the sequences encoding GUG 169–171 with a canonical
translation start site consisting of a consensus Kozak sequence followed by an AUG initiator
codon (Figure 4A). Consistent with the hypothesis that EED-1 translation actually initiates
further downstream, the resulting product was substantially larger than EED-1 (Figure 4B,
asterisk). A lower level of an EED-1 sized product, presumably initiating at the actual start site
further downstream, was also observed after transfection with this construct (Figure 4B, arrow).
Given that the deletion mapping data indicates that either the true EED-1 start site or some
regulatory element required for translation from that true EED-1 start site must map between
nucleotides 257 and 312, we hypothesized that EED-1 may be produced by translation initiating
from the previously proposed EED-2 start site at GUG 274–276. To test that possibility, we
forced expression of a protein initiating translation at that site by replacing GUG 274–276 with
a consensus Kozak followed by an AUG initiator codon (Figure 4A). Consistent with EED-1
translation initiating at this location, the resulting product was the same size as EED-1 observed
in mouse ES cells (Figure 4B).
Because EED-2 was not expressed in our wild-type ES cells or from any of our truncated
expression constructs, we were unable to characterize this isoform. However, driving
translation from a candidate start site at GUG 397–399 produced a protein that appears to be
smaller than EED-2 (data now shown), suggesting that the EED-2 start site lies between GUG
274–276 and GUG 397–399 or that EED-2 is generated by alternative mechanisms, such as
proteolytic processing.
Our deletion mapping data were consistent with presumptive EED-3 and EED-4 start sites
residing at AUG 451–453 and AUG 493–495, respectively. To confirm that translation of those
isoforms originates at those sites, we engineered AUG→AUA site directed point mutations
into the AUG 451–453 and AUG 493–495 codons (Figure 4A). Consistent with those codons
being the initiation codons for the two smaller isoforms, constructs harboring those mutations
failed to express EED-3 and EED-4 (Figure 4C).
EED isoforms are dispensible for all H3K27 methylation states
To determine whether all three EED isoforms present in our ES cells are required to mediate
the three H3K27 methylation states, H3K27 methylation was monitored in Eed mutant ES cells
transiently transfected with several of the Eed cDNA expression constructs. This rescue assay
has previously been utilized to demonstrate that protein(s) expressed from a full-length Eed
cDNA cassette can mediate all three H3K27 methylation states,1 although the role of individual
isoforms in that rescue has not been directly assessed. This approach is advantageous relative
to an isoform-specific, targeted loss-of-function approach, because it avoids the problematic
interpretation of negative results in the event that individual isoforms are dispensible for
H3K27 methylation.
Constructs harboring site-directed mutations to eliminate EED-3 and EED-4 expression or
truncated to eliminate EED-1 expression were both able to rescue all three H3K27 methylation
states in Eed mutant ES cells (Figure 5D and E). Additionally, a construct retaining only the
EED-4 start site also rescued H3K27me1, H3K27me2, and H3K27me3 (Figure 5F). As
previously reported, expression of the Eedl7Rn5–3354SB allele, which produces an unstable and
nonfunctional protein harboring a L→P substitution, failed to rescue H3K27 methylation (data
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not shown and 1). Collectively, these results demonstrate that the three H3K27 methylation
states are not dependent on individual EED isoforms.
Disruption of EED WD-40 motifs eliminates H3K27 methylation
Having demonstrated that the sequences distinguishing EED isoforms are not required for
H3K27 methylation, we attempted to assess which functional motifs common to all four EED
isoforms might be essential for PRC2 activity. EED and its homologs in other organisms are
WD-repeat proteins. However, there is disagreement about the number of WD-40 motifs
present in EED, with estimates varying between five and seven.46; 47; 48 In functional studies
assessing EED’s ability to bind EZH2 or its ability to mediate transcriptional repression when
tethered to a GAL4 DNA binding domain, only five WD-40 motifs have appeared functionally
necessary 49; 50. Those five motifs map to Eed cDNA sequences 721–808 (WD-40 motif 1),
1012–1105 (WD-40 motif 2), 1150–1240 (WD-40 motif 3), 1330–1444 (WD-40 motif 4), and
1672–1774 (WD-40 motif 5). To determine whether those same regions are required for EED’s
ability to mediate H3K27 methylation, Eed mutant ES cells were transiently transfected with
a series of Eed cDNA expression constructs progressively truncated from either the N- or C-
terminus.
A protein lacking the N-terminal 16 amino acids of EED-4 (Δ5′ 541) was able to mediate all
three H3K27 methylation states (Figure 6B), confirming that the N-terminal regions in EED,
including those amino acids that distinguish individual isoforms, are not required for the
catalytic activity of the PRC2 complex. Conversely, deletion of any of the five putative WD-40
motifs abolished EED’s ability to mediate H3K27 methylation (Figure 6D–G). An intermediate
deletion, Δ5′ 697 also left the five putative WD-40 motifs intact. However, protein expressed
from this construct retains only 8 amino acids upstream of WD-40 motif 1 and lacks a portion
of EED recently shown to be necessary for histone binding.51 Although the expression of the
Δ5′ 697 construct consistently rescued a low level of H3K27me1, little if any H3K27me2 and
H3K27me3 were observed (Figure 6C).
EED-EZH2 interaction assessed in living cells by YFP fragment complementation assays
The inability of several truncated Eed expression constructs to successfully rescue H3K27
methylation defects in Eed mutant cells could reflect an inability of these proteins to associate
with EZH2, the catalytic subunit of the PRC2 complex. In order to assess EED-EZH2
interactions, we utilized a YFP fragment complementation assay.52 In this assay, test proteins
are translationally fused to N- and C-terminal halves of Yellow Fluorescent Protein (YFP),
called Venus 1 and Venus 2, respectively. If the test proteins are able to interact, the two YFP
fragments will be close enough to reconstitute the functional fluorescent complex, which can
be assessed by fluorescence microscopy or flow cytometry.
To demonstrate the validity of the YFP fragment complementation assay, control constructs
expressing Venus 1 and Venus 2 fragments translationally fused to a homodimerizing leucine
zipper protein, GCN4, were utilized. When co-expressed in E14 ES cells, robust YFP
fluorescence was observed (Figure 7A). Similarly, Venus 1-EZH2 and EED-Venus 2 were able
to interact and reconstitute functional YFP (Figure 7C, Table 1). This fluorescence was
distributed throughout the cell and was specifically dependent on the presence of both
constructs, as expression of individual constructs failed to produce YFP activity (Figure 7H
and I).
Next, the truncated Eed cDNAs, which were tested previously for their ability to rescue H3K27
methylation defects in Eed mutant cells, were fused to Venus 2. Consistent with previous
reports,49; 50 deletion of even a single WD-40 motif from either the N- or C-terminus of EED
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appeared to abolish the EED-EZH2 interaction (Figure 7F and G, Table 1), just as they
abolished the ability to rescue H3K27 methylation (Figure 6D and G).
The Eed Δ5′ 541 truncation fully rescues H3K27 methylation despite lacking the first 16 amino
acids of EED-4 (Figure 6B). Consistent with that functional readout, in the YFP fragment
complementation assay, this protein was able to robustly interact with Venus 1-EZH2, although
at a lower level than the full length construct (Figure 7D, Table 1). Expression of the EedΔ5′
697 alllele rescued H3K27me1 but not higher H3K27 methylation states. In the YFP fragment
complentation assay, no fluorescence over background was observed upon coexpression of
Venus 1-EZH2 and EED Δ5′ 697-Venus 2, suggesting that this more severe truncation severely
limits EED’s ability to interact with EZH2.
Truncated EED protein levels
PRC2 subunits are frequently unstable outside of intact protein complexes.1; 23 As a result,
the inability of several truncated proteins to interact with EZH2 raises the possibility that these
truncated proteins are not stable. To address this possibility, levels of FLAG-tagged truncated
EED proteins were assessed by Western blotting. Consistent with its ability to bind EZH2 and
rescue H3K27 methylation, robust levels of EED Δ5′ 541 were detected in transfected cells
(Figure 8). Conversely, EED Δ5′ 697, EED Δ5′ 913, EED Δ3′ 1540-End, and Δ3′ 1324-End,
all of which fail to bind EZH2 in the Split-YFP assay, were undetectable (Figure 8).
Consequently, there was a strong correlation between H3K27me2/me3 activity, EZH2 binding,
and protein level (Figures 6–8). A striking exception to this trend was observed with the
EedΔ3′ 1663-End allele. Despite failing to bind EZH2 robustly in the YFP complementation
assay (Figure 7), this protein was stably detected in transfected cell populations (Figure 8).
Discussion
EED isoforms are not required for any H3K27 methylation state
Although the biological functions of H3K27me1 and H3K27me2 have not been defined, it is
clear from localization studies that the three H3K27 methylation states are partitioned to
nucleosomes associated with distinct regions of the genome (Figure 1 and 14; 22). Interestingly,
whereas we and others have demonstrated by immunofluorescence that foci of H3K27me1
staining colocalize with the pericentric heterochromatin, a recent study utilizing chromatin
immunoprecipitation demonstrated that H3K27me1 is found throughout chromatin (Figure 1
and 14; 22). Likely, the apparent pericentric enrichment of H3K27me1 observed by
immunofluorescence simply reflects the local enrichment of histones in the compacted
pericentric heterochromatin, as opposed to any specific enrichment of this mark as had
previously been suggested.14
Nevertheless, H3K27me1, H3K27me2, and H3K27me3 do appear to localize to nucleosomes
associated with distinct regions of the genome (Figure 1). This specificity, in turn, implies that
the number of methyl groups added to a particular nucleosome is a regulated process. In the
present study, we have defined those regions of EED required for H3K27 methylation. Initially,
we hypothesized that EED isoforms could function as regulatory switches controlling H3K27
methylation states. However, none of the EED isoforms were specifically required in order to
generate H3K27me1, H3K27me2, or H3K27me3 (Figure 5). These results demonstrate that
the N-terminal extensions discriminating EED isoforms are not required for the enzymatic
activity of the PRC2 complex.
EED WD-40 motifs and histone binding regions are required for H3K27 methylation
The ability of Eed expression constructs to rescue H3K27 methylation was dependent upon
the presence of all five EED WD-40 motifs (Figure 6). Truncated proteins lacking the N- or
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C-terminal WD-40 motif were also unable to bind to EZH2 in a YFP fragment complentation
assay (Figure 7E and F), confirming that EED-EZH2 association is likely necessary for normal
H3K27 methylation. These observations are also consistent with earlier studies indicating that
all five WD-40 motifs are required for EZH2 binding and EED-mediated transcriptional
repression.49; 50
Interestingly, whereas the Δ5′ 541 construct was able to rescue all three H3K27 methylation
states, the protein expressed from the Δ5′ 697 construct, which also retains all five WD-40
motifs, was able to mediate a low level of H3K27me1 but no H3K27me2 or H3K27me3 (Figure
6B and 6C). Recent work suggests that the N-termini of EED and of its fly homolog ESC bind
to histone H3 and that the histone binding N-terminus of ESC is required for H3K27me3.51
The Δ5′ 697 construct deletes the region of EED required for histone H3 binding. Accordingly,
the reduced levels of H3K27 methylation mediated by this construct suggest that, as in
Drosophila, the histone H3-binding N-terminus of EED may be required for full activity of
PRC2 complex. However, unlike the studies with ESC, binding between EED and EZH2 also
appears to be compromised when the histone binding domain is deleted (Figure 7E).
Furthermore, Δ5′ 697 protein levels were dramatically reduced, suggesting that the inability
to bind EZH2 may destabilize this protein (Figure 8). Given that interpretation, it is unclear
whether the reduced activity of the protein expressed from the Δ5′ 697 construct is a
consequence of its inability to bind histones or its reduced ability to bind EZH2 and resultant
instability. Finally, as a third explanation, it is possible that reduced levelsΔ5′ 697 protein could
be due to reduced expression. While formally possible, this explanation is less likely, given
that the Δ5′ 541 and Δ5′ 697 constructs have the same promoters, enhancers, 5′ and 3′ UTRs,
and canonical Kozak sequences.
EED-1, EED-3, and EED-4 translation start sites map to GUG 274–276, AUG 451–453, and
AUG 493–495
In mapping regions and motifs in EED required for H3K27 methylation, we have also defined
in vivo the translation start sites for three of the four EED isoforms. Previous work has suggested
that the four EED isoforms are generated by translation initiating at GUG 169–171, GUG 274–
276, AUG 451–453, and AUG 493–495, respectively.25; 44 This interpretation followed from
early studies by Denisenko and Bomsztyk, who assessed EED proteins translated in a cell free
system.44 Subsequently, Kuzmichev et al. generated an isoform-restricted EED antibody,
called αNT, which was raised to peptides encoded by Eed cDNA sequences from positions
258–453 (M26). Because αNT recognized EED-1 and EED-2 but not EED-3 and EED-4, those
results demonstrated that EED-1 and EED-2 must include the αNT epitope and must initiate
translation upstream of M451–453, as predicted by Denisenko and Bomsztyk.44
Here, we have directly assessed the identity of three EED translation start sites by a combination
approach involving deletion mapping, forced translation from reported start sites, and site-
directed mutagenesis of candidate initiation codons. These experiments definitively map
EED-1, EED-3, and EED-4 start sites to GUG 274–276, AUG 451–453, and AUG 493–495,
respectively. Importantly, because the informative αNT antibody utilized by Kuzmichev et
al. recognizes amino acids that would be present not only in a hypothetical protein initiating
at GUG 169–171 but also in a protein initiating at GUG 274–276, the EED-1 initiation site
reported here, the immunoblotting data from Kuzmichev et al. are fully consistent with the
results presented in the present work, even though our conclusions disagree with the
conclusions made by those authors.25
On the other hand, these results do directly contradict the earlier work of Denisenko and
Bomsztyk.44 Denisenko and Bomsztyk assessed EED proteins expressed from truncated and
engineered Eed cDNAs comparable to those utilized here. However, whereas we assessed
translation from those messages in living cells, Denisenko and Bomsztyk utilized a rabbit
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reticulocyte cell-free system. In their assay, a truncation that would have deleted the 5′ 222
nucleotides in our constructs eliminated EED-1 expression, even though a truncation extending
35 nucleotides further (Δ257) did not disrupt EED-1 expression in our assay (Figure 3B).
Additionally, Denisenko and Bomsztyk observed apparent upregulation of EED-1 after
mutating GUG 169–171 and flanking sequences to more closely resemble a canonical initiation
sequence, whereas a similar experiment in our assays produced a protein larger than EED-1
(Figure 4B).
The differences in our respective methodologies may account for the discrepancy in our results.
The major advantage to the transient transfection assay employed in this report is that it allows
direct comparison of EED expressed from expression constructs to endogenous EED expressed
in the same cell type. Moreover, a protein initiating at GUG 169–171 is predicted to be less
than 4 kDa larger than a protein initiating at GUG 274–276. In our hands, resolving proteins
initiating at those sites required large gels run at low voltage. Accordingly, differences in
electrophoresis conditions could also explain discrepancies in our results.
Conclusions
The biological functions of the four reported EED isoforms remain unclear. Both in vivo and
in vitro, all isoforms analyzed appear capable of facilitating PRC2-dependent histone
methylation (Figure 5 and 27). Accordingly, it is uncertain whether the four isoforms are even
functionally necessary in living cells. However, if isoform-specific functions do exist, the in
vivo characterization of EED isoform start sites reported here is an important first step in
defining those functions. One critical function common to the EED isoforms is the stabilization
of EZH2 in PRC2 complexes. Here, we have demonstrated that the five WD40 motifs in EED
are critical to this stabilization and to PRC2-mediated H3K27 methylation.
Materials and Methods
Cell lines and culture
CD1 murine embryonic fibroblasts (MEFs) were plated on gelatin-coated coverslips and grown
to subconfluency. Wild-type embryonic stem cell (ES) line E14, wild-type embryonic stem
(ES) cell line 25.5 and Eedl7Rn5–3354SB/l7Rn5–3354SB (herein referred to as Eed mutant or
Eed−/−) ES cell line 21 were grown first on irradiated fibroblast feeders before being plated on
coverslips without feeders and grown to subconfluency.31; 53 In transfection experiments, ES
cells plated on coverslips were transfected using Lipofectamine 2000™ (Invitrogen) and
harvested 24–48 hours later.
Immunofluorescence
Cells on coverslips were permeabilized with CSK buffer (100 mM NaCl, 300 mM sucrose, 3
mM MgCl2, 10 mM PIPES [pH 6.8]) and fixed in 4% paraformaldehyde that had been diluted
in phospho-buffered saline (PBS). To stain, cells were washed in PBS and incubated with
blocking buffer (PBS, 5% goat serum, 0.2% Tween-20, 0.2% fish skin gelatin). After blocking,
samples were incubated with primary antibody (anti-H3K27me1 [Upstate], anti-
H3K27me214, anti-H3K27me314, or anti-HP1-∝ [Upstate]), which had been diluted 1:250
in blocking buffer. Subsequently, cells were washed in PBS/0.2% Tween-20 and then
incubated with secondary antibody (Goat anti-Rabbit Alexa 594 [Molecular Probes]) diluted
1:250 in blocking buffer. Blocking and antibody incubations were always performed in a humid
chamber at 37° C. Subsequently, cells were washed again in PBS/0.2% Tween-20 and mounted
with Vectashield™ containing 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) (Vector
Laboratories). Stained slides were visualized by fluorescence microscopy, and then black and
white images were captured with a Spot CCD digital camera before being pseudo-colored and
merged with Spot software V3.5.9 (Diagnostic Instruments Inc.).
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For mapping and rescue experiment, constructs expressing Eed cDNAs were cloned into the
shuttle TA-cloning vector pGEM®-T Easy (Promega) and then subcloned into EcoRI-digested
pTarget™ (Promega) by conventional molecular biology techniques. The orientation and
identity of all inserted sequences were confirmed by fully sequencing the cDNA and the cloning
junctions.
Eed cDNAs were truncated by PCR, utilizing forward primers that annealed within the Eed
cDNA and reverse primers anchored in pTarget (primer sequences available upon request).
Site-directed point mutations were generated by standard methods. Briefly, primers spanning
EED-3 and EED-4 start sites but harboring ATG→ATA mutations were used as forward
primers with a reverse primer anchored in pTarget. Finally, in order to engineer strong
translation start sites, in frame consensus Kozak(GCCACC)-ATG 5′ extensions were included
on forward primers.
For YFP fragment complementation assays, PRC-amplified Eed and Ezh2 fragments were
cloned into split YFP expression vectors52. Briefly, Eed PCR products were TA-cloned into
pGEM®-T Easy (Promega) and then subcloned into the NotI and ClaI sites at the 5′ end of
Venus 2. Similarly, PCR-amplified Ezh2 fragments were TA-cloned before subcloning into
the the BspEI and XbaI sites at the 3′ end of Venus 1.
Western blotting
Wild-type ES cell line 25.5, wild-type ES cell line E14, mock-transfected Eed mutant ES cell
line 21, and Eed mutant ES cell line 21 transfected with various expression constructs were
harvested in urea lysis buffer (7.5 M Urea, 0.01 M Tris [pH 8.0]), 0.1M NaH2PO4) 48 hours
after transfection. Urea-lysates were also harvested from mouse Wap-T121 mammary tumor
tissue, which is generated by tissue-specific expression of T121, a fragment of SV40 T antigen
that interferes with the function of Retinoblastoma-family proteins 54. Proteins were separated
on 10% SDS-PAGE gels in Tris-Glycine running buffer and transferred to Immun-Blot PVDF
membranes (Bio-Rad) in Tris-Glycine Methanol transfer buffer. Membranes were blocked in
5% non-fat dried milk (NFDM [Food Lion])/TBST (50 mM Tris HCl [pH 7.4], 150 mM NaCl,
0.1% Tween-20) and then incubated overnight at 4° C with a mouse monoclonal anti-EED
antibody55 diluted 1:400 in 3% NFDM/TBST or Sigma M2 anti-FLAG antibody diluted
1:1000 in 3% NFDM/TBST. Membranes were vigorously washed in TBST and then incubated
overnight at 4°C with HRP-conjugated goat anti-rabbit antibody (Pierce) diluted 1:3000 in 5%
NFDM/TBST. Membranes were then vigorously washed in TBST and TBS (50 mM Tris HCl
[pH 7.4], 150 mM NaCl), before adding SuperSignal West Dura Extended Duration Substrate
(Pierce) developing reagents. Finally, blots were exposed to film and developed.
YFP fragment complementation assays
E14 ES cells grown on coverslips were transiently transfected with YFP fragment
complentation plasmids expressing GCN4, EZH2, or EED. 24 hours after transfection, the cells
were washed in 1XPBS, fixed for 20 minutes in 4% paraformaldehyde, and then washed
thoroughy in 1X PBS. Fixed cells were mounted in a polyvinyl alcohol/glycerol mounting
medium with 2% N-propyl gallate and 0.25% 1,4-diazabicyclo[2,2,2]octane. Subsequently,
YFP was visualized with a Carl Zeiss LSM5 fluorescence microscope.
For quantification of YFP fluorescence, cells were harvested 24 hours post-transfection,
trypsinized, washed in 1X PBS, and then fixed in 1% formaldehyde/PBS. Relative levels of
fluorescence were determined using a CyAn ADP flow cytometer (DakoCytomation, Inc.).
For each sample, at least 200,000 total events were analyzed. Percent of YFP positive cells and
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YFP fluorescence intensity were determined using DakoCytomation Summit software version
4.3.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Localization of Histone H3K27 methylation marks
Immunofluorescence analysis of (A) H3K27me1, (B) H3K27me2, (C) H3K27me3, and (D)
HP1-α in CD1 murine embryonic fibroblasts. The inactive X-chromosome is indicated by an
arrow in (C).
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Figure 2. Confirmation of EED isoform identities
Western blot analysis of EED comparing isoforms observed in embryonic stem cells to
isoforms observed in (A) HeLa cells or (B) Mouse Wap-T121 breast tumors. On prolonged
exposure, EED-2 becomes visible in HeLa lysates (Aright panel). EED isoforms 1–4 are
indicated as 1, 2, 3, and 4.
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Figure 3. Deletion mapping of EED translational start sites
(A) Constructs transfected into Eed mutant embryonic stem cell line 21 (below) are shown.
Putative translation start sites for EED-1 (GUG 169–171), EED-2 (GUG 274–276), EED-3
(AUG 451–453), and EED-4 (AUG 493–495) are indicated in the schematic of the endogenous
mRNA as 1,2,3, and 4 and correspond to codon locations in the mouse Eed transcript
(Accession number: BC012966). The positions of the most 5′ and 3′ nucleotides of each
construct are indicated in italics. Identifiers for each construct are shown to the left and indicate
the number of nucleotides removed from the 5′ end of the Eed cDNA (e.g. Δ210 refers to a
construct expressing an Eed cDNA lacking the 5′ 210 nucleotides of the full length message).
(B) Whole-cell lysates from Eed+/+ ES cell line 25.5 (Wild-type), Eed−/− ES cell line 21
(Mutant), or Eed−/− ES cell line 21 transiently transfected with the Eed expression constructs
shown in (A)were analyzed by Western blotting with an antibody detecting EED.
Montgomery et al. Page 17













Figure 4. Verification of EED isoform start sites
(A) Constructs transfected into Eed mutant embryonic stem cell line 21. The positions of the
most 5′ and 3′ nucleotides of each construct are indicated in italics. 1,2,3, and 4 indicate reported
EED translational start sites GUG 169–171, GUG 274–276, AUG 451–453, and AUG 493–
495, respectively. Black boxes refer to strong Kozak-AUG sequences engineered into the
expression construct in order to drive translation from the 169–171 codon (Kozak AUG 169–
171) and from the 274–276 codon (Kozak AUG 274–276), respectively. “X” markings through
the putative EED-3 and EED-4 start sites in Δ417 no3,4 and in Δ455 no4 indicate AUG→AUA
mutations intended to disrupt translation intitation. (B and C) Whole-cell lysates from
Eed+/+ ES cell line 25.5 (Wild-type), Eed−/− ES cell line 21 (Mutant), or Eed−/− ES cell line
21 transiently transfected with the Eed expression constructs shown in (A) analyzed by Western
blotting with an antibody detecting EED.
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Figure 5. Histone H3K27 methylation in cells lacking one or more EED isoforms
Immunofluorescence analysis of H3K27me1, H3K27me2, and H3K27me3 in wild-type ES
cell line 25.5 (Eed+/+) and in Eed mutant ES cell line 21 either mock transfected (Eed −/−) or
transiently transfected with the indicated constructs. Eed expression constructs transfected into
ES cell line 21 are shown on the left. The positions of the most 5′ and 3′ nucleotides of each
construct are indicated in italics. Isoform start sites at GUG 274–276, AUG 451–453, and AUG
493–495 are shown as 1*, 3, 4, respectively. 1* discrimates the GUG 274–276 start site for
EED-1 reported here from the GUG169–171 start site reported previously25; 44. “X” markings
through the putative EED-3 and EED-4 starts sites in Full length no 3,4 and in Δ417 no3,4
represent AUG→AUA mutations intended to disrupt translation intitation. EED 1036–1038
L→P refers to Eedl7Rn5–3354SB, a point mutant protein previously demonstrated to lack H3K27
methyltransferase activity. DAPI-stained DNA is blue, and methylated histones are shown in
red. In the transient transfection assay, approximately 10% of the ES cells are successfully
transfected, and with constructs expressing functional EED, a similar percentage of cells are
rescued.
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Figure 6. Functional mapping of required WD-40 motifs in EED
Immunofluorescence analysis of H3K27me3 in Eed mutant ES cell line 21 either mock
transfected (Eed−/−) or transiently transfected with the indicated constructs. Below each
schematic, nucleotides encoding for the N- and C-terminal amino acids of each protein are
indicated in italics. Above each schematic, “3” and “4” refer to translation start sites for EED
isoforms 3 and 4. Diagonally-lined boxes refer to putative WD-40 motifs encoded by cDNA
sequences 721–808 (WD-40 motif 1), 1012–1105 (WD-40 motif 2), 1150–1240 (WD-40 motif
3), 1330–1444 (WD-40 motif 4), and 1672-1774 (WD-40 motif 5) 49. Black boxes refer to
consensus Kozak + ATG initiator sequences engineered into the construct. DAPI-stained DNA
is blue, and methylated histone are shown in red.
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Figure 7. EED-EZH2 interaction assessed by YFP fragment complentation assays
YFP fragment complentation assays in E14 ES cells transiently transfected with constructs
expressing the following Venus 1 and Venus 2 fusions: (A) Venus1-GCN4 and GCN4-Venus2,
(B) no DNA, (C) Venus1-EZH2 and Full length EED3-Venus2, (D) Venus1-EZH2 and EED
Δ5′ 541-Venus2, (E) Venus1-EZH2 and EED Δ5′ 697-Venus2, (F) Venus1- EZH2 and EED
Δ5′ 913-Venus2, (G) Venus1-EZH2 and EED Δ3′ 1663-End-Venus2, (H) Venus1-EZH2 and
no Venus 2, and (I) no Venus 1 and Full length EED3-Venus2.
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Figure 8. Levels of truncated EED proteins
The stability of truncated, tagged EED proteins was assessed by Western blotting lysates from
transfected E14 embryonic stem cells with an anti-FLAG antibody. Three background bands
observed with the FLAG antibody serve as loading controls and are indicated by asterisks.
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Table 1
Split YFP Complementation by EED-EZH2 Interaction
Percentage of Positive Cells
Full-length 11.27 ± 0.33
Δ5′ 541 6.21 ± 0.52
Δ5′ 697 0.18 ± 0.04
Δ5′ 913 0.12 ± 0.02
Δ3′ 1663-End 0.28 ± 0.05
No transfect 0 ± 0
Legend: E14 embryonic stem cells were cotransfected with Venus 1-EZH2 and EED-Venus 2 expression constructs. 24 hours post-transfection, triplicate
samples were analyzed by FACS. The mean percentage of YFP-positive cells and corresponding standard deviation from a representative experiment are
shown.
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